Annals of Internal Medicine tip sheet, July 18, 2006

July 17, 2006

15.5 Percent of U.S. teens are overweight. Two articles and an editorial in this issue of annals focus on adolescent obesity

1. Adolescent Female Obesity Can Lead to Premature Death as an Adult

A study of 102,400 female nurses found that a higher than normal body mass index (BMI) at age 18 was associated with greater risk for death than a normal BMI, even after statistical adjustment for risk factors such as smoking, alcohol use and physical activity (Article, p. 91).

The participants, who were aged 24 to 44 at the start of the 12-year study, recalled their weight at age 18. A total of 710 participants died.

2. Diet Drug Plus Therapy Helped Very Obese Adolescents Lose Weight

In a 22 center study of 498 severely obese adolescents, those who received the diet drug sibutramine along with behavior therapy lost an average of 14 pounds at the end of one year of treatment, while a group who received a dummy pill (placebo) with the therapy gained about four pounds (Article, p. 81).

The sibutramine group also had improved profiles of several heart risk factors, such as triglyceride levels, high-density lipoprotein cholesterol levels, insulin levels, and insulin sensitivity.

The participants, who were 12 to 16 years old, weighed on average 215 pounds at the beginning of the study.

3. Editorial Writer Says Prevention of Obesity is Best Long-Term Solution

An editorial writer says that the sibutramine study is useful because there have been few randomized trials evaluating drug therapies for overweight adolescents (Editorial, p. 145).

But the writer cautioned that the study does not show what part of the weight loss came from the drug, increased physical activity, or counseling.

Further, for long-term success, and to avoid the risk or premature death identified in the nurses' study above, people must avoid regaining the excess weight lost during treatment. Does this mean that they would have to take the diet drug for life?

"Because drug therapy is likely to have higher lifetime risks and costs than behavioral interventions, physicians should aim for sustained behavior change and reserve drug therapy for the severely overweight adolescent who cannot otherwise lose weight," the writer says.

Finally, preventing overweight should be a high public health priority, according to the editorial writer, who gives nine strategies for preventing weight gain.
-end-


American College of Physicians

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.